Azithromycin for Horses: Uses, Dosing & Side Effects

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Azithromycin is a macrolide antibiotic. In equine medicine, it is used most often in foals, not adult horses. It is valued because it penetrates tissues well and can concentrate inside cells, which matters for infections caused by bacteria that hide within inflammatory cells.

The best-known equine use is treatment of Rhodococcus equi pneumonia in foals, usually as part of a combination plan with rifampin. This infection tends to affect foals between about 1 and 5 months of age, and treatment often needs to continue for weeks, guided by your vet’s exam and repeat imaging.

Azithromycin is considered extra-label in horses, which means your vet prescribes it based on veterinary judgment rather than a horse-specific FDA label. That is common in equine practice. Because horses can react differently to antibiotics than dogs or cats, your vet will weigh age, nursing status, heat exposure, hydration, and the risk of intestinal complications before choosing it.

Azithromycin is used most commonly for confirmed or strongly suspected Rhodococcus equi pneumonia in foals. Major equine references recommend a macrolide plus rifampin for foals with clinically important disease, especially when imaging and airway samples support the diagnosis. In some cases, your vet may also consider it for other susceptible respiratory infections or internal abscesses.

This medication is not a routine antibiotic for adult horses. Macrolides, including azithromycin, have been associated with severe and sometimes fatal colitis in adult horses, so equine vets are usually very cautious about adult use. Even when only the foal is being treated, drug residue around the muzzle or in manure can expose the mare, which is why careful handling matters.

Azithromycin is not the right choice for every coughing foal. Some small lung lesions can resolve without antibiotics, while severe cases may need a different macrolide, oxygen support, anti-inflammatory medication, fluids, or hospitalization. Your vet decides whether treatment is needed based on the foal’s breathing, fever, ultrasound or radiographs, and sometimes tracheal wash testing.

Typical equine dosing references list azithromycin at 10 mg/kg by mouth every 24 hours for 5 days, then every 48 hours, generally in combination with rifampin for foals with Rhodococcus equi pneumonia. Merck also lists an IV protocol of 5 mg/kg every 24 hours for 5 days, then every 48 hours, but route, formulation, and monitoring are decisions for your vet.

Treatment duration is often 2 to 12 weeks, depending on how sick the foal is and how quickly lung lesions improve on ultrasound or radiographs. Stopping too early can lead to relapse, while continuing too long can increase adverse-effect and resistance concerns. That is why follow-up exams matter.

Do not calculate a dose on your own from internet charts. Foal age, body weight, severity of pneumonia, whether rifampin is also being used, and whether the foal is nursing all affect the plan. Your vet may also adjust management during treatment, such as keeping the foal in a cool, shaded, well-ventilated area and rinsing or wiping the muzzle after dosing to reduce accidental exposure to the mare.

The most important side effects in foals are diarrhea, reduced sweating or inability to sweat normally, hyperthermia, and sometimes faster breathing. Hyperthermia can become dangerous quickly, especially in hot weather or direct sun. If a foal on azithromycin seems unusually warm, weak, dull, or is breathing harder, contact your vet right away.

A second major concern is antibiotic-associated colitis in adult horses, including the mare of a nursing foal. Even indirect exposure to macrolides has been linked to life-threatening intestinal disease in mares. If the mare develops diarrhea, depression, fever, or reduced appetite while the foal is being treated, see your vet immediately.

Less commonly, long treatment courses may contribute to appetite changes or other gastrointestinal upset. Any worsening cough, persistent fever, poor nursing, weight loss, or new colic signs during treatment should prompt a recheck. Side effects do not always mean the drug must be stopped, but they do mean the treatment plan needs veterinary review.

The interaction your vet thinks about most often is azithromycin with rifampin. These drugs are commonly used together for foal pneumonia because they work against intracellular Rhodococcus equi, but rifampin can also change how companion drugs are absorbed, transported, and metabolized. In practice, that means your vet may be thoughtful about timing, monitoring response, and adjusting the plan if the foal is not improving as expected.

Azithromycin belongs to the macrolide family, so your vet will also review any other medications that may affect the gut, liver handling of drugs, or overall tolerance of therapy. Because sick foals may also receive NSAIDs, fluids, nebulization, or other antibiotics, the full medication list matters.

Tell your vet about every product the foal and mare are getting, including supplements, ulcer medications, probiotics, and anything given by another barn caregiver. Do not combine antibiotics or change schedules without approval. With equine antibiotics, small changes in timing or drug choice can affect both safety and treatment success.